Dyadic to present at bioprocess international

Jupiter, fla., sept. 12, 2023 (globe newswire) -- dyadic international, inc. (“dyadic”, or the “company”) (nasdaq: dyai), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein bioproduction and unmet clinical needs for effective, affordable and accessible biopharmaceutical products for human and animal health, and alternative proteins for food, nutrition and wellness, today announced that joseph hazelton, chief business officer of dyadic will be presenting at bioprocess international.
DYAI Ratings Summary
DYAI Quant Ranking